NCT Number: NCT04349501
Phase: Phase 2
Trial Summary: Adult male patients with high-risk, localized prostate cancer and planning to undergo radiation therapy (RT) with androgen deprivation therapy (ADT) will undergo an advanced Magnet – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): University of California, San Diego
Acronym: ProsRSI
Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI)
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives